Why the study?
Do aliskiren, valsartan, and their combination reduce stress metabolites and improve cognitive function in rats?
Do aliskiren, valsartan, and their combination reduce stress metabolites and improve cognitive function in rats?
Aliskiren and valsartan demonstrate anti-stress and nootropic effects in rat models, providing a potential neurochemical basis for cognitive benefits of these antihypertensive agents.
Answers are grounded in this paper and cite their sources.
Animal data suggest potential cognitive benefits of renin-angiotensin modulators; leaves open translation to human stress or memory disorders.
INTRODUCTION: Various stress hormones are responsible for bringing out stress-related changes and are implicated in learning and memory processes. The extensive clinical experience of angiotensin receptor blockers (ARBs) and direct renin inhibitor as antihypertensive agents provides anecdotal evidence of improvements in cognition. The neurochemical basis underlying the anti-stress and nootropic effects are unclear. This study was aimed to determine the effects of aliskiren, valsartan and their combination on the neuromediators of the central nervous system (CNS) and periphery as well as on cognitive function. MATERIALS AND METHODS: Groups of rats were subjected to a forced swim stress for one hour after daily treatment with aliskiren, valsartan and their combination. The 24 h urinary excretion of vanillylmandellic acid (VMA), 5-hydroxyindoleacetic acid (5-HIAA), 6-β-hydroxycortisol (6-β-OH) cortisol and homovanillic acid (HVA) was determined in all groups under normal and stressed conditions. Nootropic activity was studied using cook's pole climbing apparatus and acetylcholinesterase (AChE) inhibitory activity by Ellman's method. RESULTS: Administration of aliskiren (10 mg/kg), valsartan (20 mg/kg) and their combination at a dose of 5 and 10 mg/kg respectively reduced the urinary metabolite levels. Further, all drugs showed significant improvement in scopolamine-impaired performance and produced inhibition of the AChE enzyme. CONCLUSIONS: The present study provides scientific support for the anti-stress and nootropic activities of aliskiren, valsartan and their combination.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2014) studied Stress and cognitive impairment. Aliskiren, valsartan, and their combination vs. Control (normal and stressed conditions) was evaluated on Urinary excretion of stress metabolites and scopolamine-impaired performance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: